Anticoagulation

ACC.24 Late-breaking Science Preview

Listen time: 28m 10s
View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 28m 9s
EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: The RIGHT Study

Yan Yan, Gilles Montalescot,

Watch time: 5m 21s
ESC 23: The ONCO DVT Study

Yugo Yamashita,

Watch time: 4m 8s
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s

Sonika Malik , Anju Bhardwaj , Matthew Eisen , et al

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Alex Spyropoulos, Gary E Raskob,

Watch time: 1h 2m 6s

Yugo Yamashita,

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Karthiek R Narala , Thomas A LaLonde , Sohail Hassan , et al

Robert Barcelona ,

Read time: 23m

Payam Pournazari , Su Min Chang , Stephen H Little , et al

Donald E Cutlip ,

Johny Nicolas , Usman Baber , Roxana Mehran ,

Media

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

Yugo Yamashita,

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s

Watch time: 3h 52m 31s
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 28m 6s

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

Media

ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 28m 9s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
View from the Thoraxcenter – What's hot at ACC 2020

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 17m 52s
ACC 2020: Update from the TWILIGHT Study — Prof Dominick J Angiolillo

Dominick J Angiolillo,

Watch time: 11m
HRS 2020: Incidence of Silent Brain Infarcts in Anticoagulated Patients with AF

David Conen,

Watch time: 7m 38s
Dr Steven Lubitz

Watch time: 5m 24s

Yugo Yamashita,

CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s

Articles

Non-ST-segment Elevation Acute Coronary Syndromes

Sandeep Nathan

,

Rajiv Swamy

,

Citation:

US Cardiology 2008;5(1):16–21

DOI:

https://doi.org/10.15420/usc.2008.5.1.16
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 479
  • Downloads: Downloads 5

Platelet Function Testing in High-risk Coronary Artery Disease Patients - An Update

Rita Paniccia

,

Citation:

US Cardiology 2009;6(1):75–80

DOI:

https://doi.org/10.15420/usc.2009.6.1.75
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 450
  • Downloads: Downloads 4

Anti-platelet Therapy for Congestive Heart Failure

Victor L Serebruany

,

Citation:

US Cardiology 2004;1(1):1–6

Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 801
  • Downloads: Downloads 5

Atrial Fibrillation—Recent Key Trials on Anticoagulation

Stefan H Hohnloser

,

Citation:

US Cardiology 2007;4(1):18–9

DOI:

https://doi.org/10.15420/usc.2007.4.1.18
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1308
  • Downloads: Downloads 4